FI71314C - Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt - Google Patents
Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt Download PDFInfo
- Publication number
- FI71314C FI71314C FI821324A FI821324A FI71314C FI 71314 C FI71314 C FI 71314C FI 821324 A FI821324 A FI 821324A FI 821324 A FI821324 A FI 821324A FI 71314 C FI71314 C FI 71314C
- Authority
- FI
- Finland
- Prior art keywords
- calcium
- diphenyloxazol
- propionsyrakalciumsalt
- framework
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8113074 | 1981-04-28 | ||
GB8113074 | 1981-04-28 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI821324A0 FI821324A0 (fi) | 1982-04-15 |
FI821324L FI821324L (fi) | 1982-10-29 |
FI71314B FI71314B (fi) | 1986-09-09 |
FI71314C true FI71314C (fi) | 1986-12-19 |
Family
ID=10521427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI821324A FI71314C (fi) | 1981-04-28 | 1982-04-15 | Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt |
Country Status (24)
Country | Link |
---|---|
US (2) | US4465838A (ja) |
EP (1) | EP0063884B1 (ja) |
JP (1) | JPS57181072A (ja) |
KR (1) | KR880000871B1 (ja) |
AT (1) | ATE14015T1 (ja) |
AU (1) | AU544975B2 (ja) |
CA (1) | CA1169867A (ja) |
CS (1) | CS236674B2 (ja) |
DD (1) | DD202017A5 (ja) |
DE (1) | DE3264400D1 (ja) |
DK (1) | DK150604C (ja) |
ES (1) | ES8307230A1 (ja) |
FI (1) | FI71314C (ja) |
GR (1) | GR75913B (ja) |
HU (1) | HU185276B (ja) |
IE (1) | IE52909B1 (ja) |
IL (1) | IL65443A (ja) |
MY (1) | MY8700599A (ja) |
NZ (1) | NZ200247A (ja) |
PH (1) | PH18053A (ja) |
PL (1) | PL136322B1 (ja) |
PT (1) | PT74794B (ja) |
ZA (1) | ZA822355B (ja) |
ZW (1) | ZW7482A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US6726928B2 (en) * | 1994-10-28 | 2004-04-27 | R.P. Scherer Technologies, Inc. | Process for preparing solid dosage forms for unpalatable pharmaceuticals |
KR20000015865A (ko) * | 1996-05-20 | 2000-03-15 | 윌리암스 로저 에이 | 칼륨, 나트륨 및 트리스옥사프로진염의 약학적 제제 |
US7358254B2 (en) * | 2001-07-13 | 2008-04-15 | Bristol-Myers Squibb Company | Method for treating atherosclerosis employing an aP2 inhibitor and combination |
US20060222671A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Development A/S | Dermatological compositions and salts for the treatment of dermatological diseases |
AU2006228869A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Pharma A/S | Oxaprozin or a closely related compound for the treatment of eczema |
DK2340296T3 (da) * | 2008-08-26 | 2015-01-19 | Dorf Ketal Chemicals I Private Ltd | Nyt additiv til inhibering af syrekorrosion og fremgangsmåder til anvendelse af det nye additiv |
KR20140065862A (ko) * | 2012-11-22 | 2014-05-30 | 에스케이케미칼주식회사 | 발포성 속붕해성 이매티닙 제제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1206403A (en) * | 1966-12-15 | 1970-09-23 | Wyeth John & Brother Ltd | Oxazoles |
GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
-
1982
- 1982-03-31 IE IE766/82A patent/IE52909B1/en not_active IP Right Cessation
- 1982-04-05 CA CA000400464A patent/CA1169867A/en not_active Expired
- 1982-04-05 ZA ZA822355A patent/ZA822355B/xx unknown
- 1982-04-06 NZ NZ200247A patent/NZ200247A/en unknown
- 1982-04-06 IL IL65443A patent/IL65443A/xx not_active IP Right Cessation
- 1982-04-06 AU AU82378/82A patent/AU544975B2/en not_active Expired
- 1982-04-07 EP EP82301839A patent/EP0063884B1/en not_active Expired
- 1982-04-07 AT AT82301839T patent/ATE14015T1/de not_active IP Right Cessation
- 1982-04-07 DE DE8282301839T patent/DE3264400D1/de not_active Expired
- 1982-04-09 GR GR67879A patent/GR75913B/el unknown
- 1982-04-15 ZW ZW74/82A patent/ZW7482A1/xx unknown
- 1982-04-15 FI FI821324A patent/FI71314C/fi not_active IP Right Cessation
- 1982-04-22 PH PH27171A patent/PH18053A/en unknown
- 1982-04-23 JP JP57069463A patent/JPS57181072A/ja active Granted
- 1982-04-23 DK DK183582A patent/DK150604C/da not_active IP Right Cessation
- 1982-04-26 US US06/371,904 patent/US4465838A/en not_active Expired - Lifetime
- 1982-04-26 PL PL1982236145A patent/PL136322B1/pl unknown
- 1982-04-26 PT PT74794A patent/PT74794B/pt unknown
- 1982-04-26 KR KR8201829A patent/KR880000871B1/ko active
- 1982-04-27 DD DD82239350A patent/DD202017A5/de not_active IP Right Cessation
- 1982-04-27 ES ES511730A patent/ES8307230A1/es not_active Expired
- 1982-04-27 HU HU821325A patent/HU185276B/hu unknown
- 1982-04-28 CS CS823052A patent/CS236674B2/cs unknown
-
1984
- 1984-07-11 US US06/629,704 patent/US4532253A/en not_active Expired - Lifetime
-
1987
- 1987-12-30 MY MY599/87A patent/MY8700599A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI71314B (fi) | Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt | |
GB2037306A (en) | Cyclodextrin-camomile inclusion complexes and pharmaceutical compositions containing them | |
US4073895A (en) | Isopropylamino pyrimidine orthophosphate | |
JPS59148789A (ja) | 高度に結晶性のナトリウムセフオペラゾンの製法 | |
US3028420A (en) | Compound of betaine and chloral and method for preparing same | |
ES8308833A1 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
RU2126402C1 (ru) | Способ селективного получения 3/2 гидрата 7-[(7-(s)-амино-5-азаспиро [2,4] гептан- 5-ил]-8-хлор-6-фтор-1- [(1r, 2s)-2-фторциклопропил]-4-оксо-1,4-дегидрохинолин-3- карбоновой кислоты, безводная 7-[(7-(s)-амино-5-азаспиро [2,4] гептан-5-ил]-8-хлор-6- фтор-1- (1r, 2s)-2-фторциклопропил-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота и фармацевтическая композиция, обладающая антибактериальной активностью | |
JPH0365338B2 (ja) | ||
EP0773783B1 (en) | Preparation of fusidic acid tablets | |
DE1670389A1 (de) | Neue quaternaere 5-Ammonium-methyl-4-amino-pyrimidinsalzverbindungen | |
CA1132562A (en) | Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use | |
EP0058079B1 (en) | 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate, method of preparation thereof, and pharmaceutical composition containing same | |
NO771828L (no) | 3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstilling | |
JPS604189B2 (ja) | 抗菌剤およびその製法 | |
US3905959A (en) | Process for the manufacture of crystalline anhydrous ampicillin | |
DE2706841C2 (ja) | ||
JPS62294616A (ja) | 抗真菌用薬剤 | |
GB2054556A (en) | Preparation of hydroxy derivatives of 2-isopropylamino-pyrimidine | |
US4959394A (en) | Novel Guanidinium aspartates | |
KR100257967B1 (ko) | 피리독신 5-옥소-2-피롤리돈 카르복실레이트의 제조공정 | |
JPS5626709A (en) | Manufacture of water soluble iron salt | |
US6271397B1 (en) | L-ascorbic acid-2-phosphoric acid potassium crystal and method for producing the same | |
GB2097389A (en) | Oxazole derivative | |
US3644395A (en) | Phenylbutazone-sodium-monoglycerate | |
EP0153171A2 (en) | New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |
Owner name: JOHN WYETH & BROTHER LIMITED |